Detection of high‐grade cervical disease among women referred directly to colposcopy after a positive HPV screening test varies with age and cytology findings
Australia's new HPV‐based cervical screening program is based on an algorithm that incorporates reflex cytology to guide decisions about further follow‐up with colposcopy and, if indicated, biopsy. We reviewed results for 2300 women referred directly for colposcopy after their first positive HP...
Saved in:
| Published in | International journal of cancer Vol. 147; no. 11; pp. 3068 - 3074 |
|---|---|
| Main Authors | , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
Hoboken, USA
John Wiley & Sons, Inc
01.12.2020
Wiley Subscription Services, Inc |
| Subjects | |
| Online Access | Get full text |
| ISSN | 0020-7136 1097-0215 1097-0215 |
| DOI | 10.1002/ijc.33128 |
Cover
| Abstract | Australia's new HPV‐based cervical screening program is based on an algorithm that incorporates reflex cytology to guide decisions about further follow‐up with colposcopy and, if indicated, biopsy. We reviewed results for 2300 women referred directly for colposcopy after their first positive HPV screening test, to determine the proportion that had underlying histological high‐grade abnormality (HGA). Overall, HGA was detected in 24.3% of women. Among HPV16/18 positive women, 18.0% had HGA, increasing from 6.6% among women with negative cytology to 79.7% among women with high‐grade squamous lesion or worse, or any glandular lesion on cytology (HSIL+; P‐trend < .001). For this latter group, the proportion with HGA was higher among HPV16/18 positive women than among those positive for other oncogenic types (68.8%; P = .029). Among women with ASC‐H cytology, 51.8% had HGA, with no difference between HPV groups (P = .314). In analyses by age‐groups, detection of HGA was highest, at 36.4%, among women younger than 35 years, then decreased significantly to 5.9%, among women aged 65 to 74 years (P‐trend < .001). The relationship of decreasing HGA detection with increasing age was strong for women with negative cytology, and those with ASC‐H cytology (P‐trend < .001 for each). For women with HSIL+ cytology, detection of HGA was high and stable, regardless of age (P‐trend = .211). This report describes the first follow‐up colposcopy findings in Australia's new HPV‐based cervical screening program. The results demonstrate the additional value of reflex cytology in managing HPV positive women and suggest that further refinement of the risk‐based algorithm to account for age may be warranted.
What's new?
Australia's new human papilloma virus (HPV)‐based cervical screening program relies on a risk‐based algorithm incorporating reflex cytology to guide decisions about follow‐up colposcopy. In this report of the first follow‐up colposcopy findings, nearly one in four women referred directly for colposcopy under the algorithm had an underlying histological high‐grade abnormality (HGA). Detection of HGA increased with increasing grade of reflex cytology, but there was a substantial reduction in HGA detection with increasing age. The results demonstrate the additional value of reflex cytology in managing HPV‐positive women and suggest that the risk‐based algorithm should be further refined to account for age. |
|---|---|
| AbstractList | Australia's new HPV-based cervical screening program is based on an algorithm that incorporates reflex cytology to guide decisions about further follow-up with colposcopy and, if indicated, biopsy. We reviewed results for 2300 women referred directly for colposcopy after their first positive HPV screening test, to determine the proportion that had underlying histological high-grade abnormality (HGA). Overall, HGA was detected in 24.3% of women. Among HPV16/18 positive women, 18.0% had HGA, increasing from 6.6% among women with negative cytology to 79.7% among women with high-grade squamous lesion or worse, or any glandular lesion on cytology (HSIL+; P-trend < .001). For this latter group, the proportion with HGA was higher among HPV16/18 positive women than among those positive for other oncogenic types (68.8%; P = .029). Among women with ASC-H cytology, 51.8% had HGA, with no difference between HPV groups (P = .314). In analyses by age-groups, detection of HGA was highest, at 36.4%, among women younger than 35 years, then decreased significantly to 5.9%, among women aged 65 to 74 years (P-trend < .001). The relationship of decreasing HGA detection with increasing age was strong for women with negative cytology, and those with ASC-H cytology (P-trend < .001 for each). For women with HSIL+ cytology, detection of HGA was high and stable, regardless of age (P-trend = .211). This report describes the first follow-up colposcopy findings in Australia's new HPV-based cervical screening program. The results demonstrate the additional value of reflex cytology in managing HPV positive women and suggest that further refinement of the risk-based algorithm to account for age may be warranted.Australia's new HPV-based cervical screening program is based on an algorithm that incorporates reflex cytology to guide decisions about further follow-up with colposcopy and, if indicated, biopsy. We reviewed results for 2300 women referred directly for colposcopy after their first positive HPV screening test, to determine the proportion that had underlying histological high-grade abnormality (HGA). Overall, HGA was detected in 24.3% of women. Among HPV16/18 positive women, 18.0% had HGA, increasing from 6.6% among women with negative cytology to 79.7% among women with high-grade squamous lesion or worse, or any glandular lesion on cytology (HSIL+; P-trend < .001). For this latter group, the proportion with HGA was higher among HPV16/18 positive women than among those positive for other oncogenic types (68.8%; P = .029). Among women with ASC-H cytology, 51.8% had HGA, with no difference between HPV groups (P = .314). In analyses by age-groups, detection of HGA was highest, at 36.4%, among women younger than 35 years, then decreased significantly to 5.9%, among women aged 65 to 74 years (P-trend < .001). The relationship of decreasing HGA detection with increasing age was strong for women with negative cytology, and those with ASC-H cytology (P-trend < .001 for each). For women with HSIL+ cytology, detection of HGA was high and stable, regardless of age (P-trend = .211). This report describes the first follow-up colposcopy findings in Australia's new HPV-based cervical screening program. The results demonstrate the additional value of reflex cytology in managing HPV positive women and suggest that further refinement of the risk-based algorithm to account for age may be warranted. Australia's new HPV-based cervical screening program is based on an algorithm that incorporates reflex cytology to guide decisions about further follow-up with colposcopy and, if indicated, biopsy. We reviewed results for 2300 women referred directly for colposcopy after their first positive HPV screening test, to determine the proportion that had underlying histological high-grade abnormality (HGA). Overall, HGA was detected in 24.3% of women. Among HPV16/18 positive women, 18.0% had HGA, increasing from 6.6% among women with negative cytology to 79.7% among women with high-grade squamous lesion or worse, or any glandular lesion on cytology (HSIL+; P-trend < .001). For this latter group, the proportion with HGA was higher among HPV16/18 positive women than among those positive for other oncogenic types (68.8%; P = .029). Among women with ASC-H cytology, 51.8% had HGA, with no difference between HPV groups (P = .314). In analyses by age-groups, detection of HGA was highest, at 36.4%, among women younger than 35 years, then decreased significantly to 5.9%, among women aged 65 to 74 years (P-trend < .001). The relationship of decreasing HGA detection with increasing age was strong for women with negative cytology, and those with ASC-H cytology (P-trend < .001 for each). For women with HSIL+ cytology, detection of HGA was high and stable, regardless of age (P-trend = .211). This report describes the first follow-up colposcopy findings in Australia's new HPV-based cervical screening program. The results demonstrate the additional value of reflex cytology in managing HPV positive women and suggest that further refinement of the risk-based algorithm to account for age may be warranted. Australia's new HPV‐based cervical screening program is based on an algorithm that incorporates reflex cytology to guide decisions about further follow‐up with colposcopy and, if indicated, biopsy. We reviewed results for 2300 women referred directly for colposcopy after their first positive HPV screening test, to determine the proportion that had underlying histological high‐grade abnormality (HGA). Overall, HGA was detected in 24.3% of women. Among HPV16/18 positive women, 18.0% had HGA, increasing from 6.6% among women with negative cytology to 79.7% among women with high‐grade squamous lesion or worse, or any glandular lesion on cytology (HSIL+; P‐trend < .001). For this latter group, the proportion with HGA was higher among HPV16/18 positive women than among those positive for other oncogenic types (68.8%; P = .029). Among women with ASC‐H cytology, 51.8% had HGA, with no difference between HPV groups (P = .314). In analyses by age‐groups, detection of HGA was highest, at 36.4%, among women younger than 35 years, then decreased significantly to 5.9%, among women aged 65 to 74 years (P‐trend < .001). The relationship of decreasing HGA detection with increasing age was strong for women with negative cytology, and those with ASC‐H cytology (P‐trend < .001 for each). For women with HSIL+ cytology, detection of HGA was high and stable, regardless of age (P‐trend = .211). This report describes the first follow‐up colposcopy findings in Australia's new HPV‐based cervical screening program. The results demonstrate the additional value of reflex cytology in managing HPV positive women and suggest that further refinement of the risk‐based algorithm to account for age may be warranted. What's new? Australia's new human papilloma virus (HPV)‐based cervical screening program relies on a risk‐based algorithm incorporating reflex cytology to guide decisions about follow‐up colposcopy. In this report of the first follow‐up colposcopy findings, nearly one in four women referred directly for colposcopy under the algorithm had an underlying histological high‐grade abnormality (HGA). Detection of HGA increased with increasing grade of reflex cytology, but there was a substantial reduction in HGA detection with increasing age. The results demonstrate the additional value of reflex cytology in managing HPV‐positive women and suggest that the risk‐based algorithm should be further refined to account for age. Australia's new HPV‐based cervical screening program is based on an algorithm that incorporates reflex cytology to guide decisions about further follow‐up with colposcopy and, if indicated, biopsy. We reviewed results for 2300 women referred directly for colposcopy after their first positive HPV screening test, to determine the proportion that had underlying histological high‐grade abnormality (HGA). Overall, HGA was detected in 24.3% of women. Among HPV16/18 positive women, 18.0% had HGA, increasing from 6.6% among women with negative cytology to 79.7% among women with high‐grade squamous lesion or worse, or any glandular lesion on cytology (HSIL+; P ‐trend < .001). For this latter group, the proportion with HGA was higher among HPV16/18 positive women than among those positive for other oncogenic types (68.8%; P = .029). Among women with ASC‐H cytology, 51.8% had HGA, with no difference between HPV groups ( P = .314). In analyses by age‐groups, detection of HGA was highest, at 36.4%, among women younger than 35 years, then decreased significantly to 5.9%, among women aged 65 to 74 years ( P ‐trend < .001). The relationship of decreasing HGA detection with increasing age was strong for women with negative cytology, and those with ASC‐H cytology ( P ‐trend < .001 for each). For women with HSIL+ cytology, detection of HGA was high and stable, regardless of age ( P ‐trend = .211). This report describes the first follow‐up colposcopy findings in Australia's new HPV‐based cervical screening program. The results demonstrate the additional value of reflex cytology in managing HPV positive women and suggest that further refinement of the risk‐based algorithm to account for age may be warranted. What's new? Australia's new human papilloma virus (HPV)‐based cervical screening program relies on a risk‐based algorithm incorporating reflex cytology to guide decisions about follow‐up colposcopy. In this report of the first follow‐up colposcopy findings, nearly one in four women referred directly for colposcopy under the algorithm had an underlying histological high‐grade abnormality (HGA). Detection of HGA increased with increasing grade of reflex cytology, but there was a substantial reduction in HGA detection with increasing age. The results demonstrate the additional value of reflex cytology in managing HPV‐positive women and suggest that the risk‐based algorithm should be further refined to account for age. |
| Author | Roberts, Jennifer M. Crescini, Joanne Machalek, Dorothy A. Garland, Suzanne M. Farnsworth, Annabelle Kaldor, John M. |
| Author_xml | – sequence: 1 givenname: Annabelle orcidid: 0000-0002-2358-4972 surname: Farnsworth fullname: Farnsworth, Annabelle email: afarnsworth@dhm.com.au organization: University of Notre Dame – sequence: 2 givenname: Jennifer M. surname: Roberts fullname: Roberts, Jennifer M. organization: Douglass Hanly Moir Pathology – sequence: 3 givenname: Suzanne M. surname: Garland fullname: Garland, Suzanne M. organization: Murdoch Children's Research Institute – sequence: 4 givenname: Joanne surname: Crescini fullname: Crescini, Joanne organization: Douglass Hanly Moir Pathology – sequence: 5 givenname: John M. surname: Kaldor fullname: Kaldor, John M. organization: University of New South Wales – sequence: 6 givenname: Dorothy A. surname: Machalek fullname: Machalek, Dorothy A. organization: University of Melbourne |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/32484236$$D View this record in MEDLINE/PubMed |
| BookMark | eNp9kUuOEzEQhi00iMkEFlwAWWIDi57xo92PJQqPGTQSLIBty22XO4667WA7iXrHETgCZ-MkOGRgMRKoFqVSff-vUv0X6Mx5Bwg9peSSEsKu7EZdck5Z8wAtKGnrgjAqztAi70hRU16do4sYN4RQKkj5CJ1zVjYl49UC_XgNCVSy3mFv8NoO65_fvg9BasAKwt4qOWJtI8gIWE7eDfjgJ3A4gIEQQOdlyPpxxslj5cetj8pvZyxNgoAlzrNNdg_4-uMXHFUAcDabJIgJ72WwEPHBpjWWQ_Z3Gqs5-dEPMzbW6UzGx-ihkWOEJ3d9iT6_ffNpdV3cfnh3s3p1WyhWNU1RadXwnhrRtqQuVWuIEQBa9YQSLUGLBrRpZKmENpxSRiTvlahJTSop6l7zJXpx8t0G_3WXz-smGxWMo3Tgd7FjJWkaxo-1RM_voRu_Cy5fl6myLZlgXGTq2R216yfQ3TbYSYa5-_P7DLw8ASr4GPND_yKUdMdcu5xr9zvXzF7dY5VN8hhbCtKO_1Mc7Ajzv627m_erk-IX0Ci3GA |
| CitedBy_id | crossref_primary_10_3390_cancers13061224 crossref_primary_10_1159_000521911 crossref_primary_10_1111_aogs_14121 crossref_primary_10_1177_0969141321992404 crossref_primary_10_1002_ijc_34393 crossref_primary_10_1002_ijc_35185 crossref_primary_10_3389_fpubh_2022_950610 crossref_primary_10_3390_diagnostics12112585 crossref_primary_10_1002_jmv_29475 crossref_primary_10_1097_LGT_0000000000000861 crossref_primary_10_1016_j_pmedr_2022_101929 crossref_primary_10_1111_ajo_13684 crossref_primary_10_1371_journal_pone_0299651 crossref_primary_10_1016_j_jiph_2023_06_016 crossref_primary_10_1186_s12905_023_02538_2 |
| Cites_doi | 10.1002/ijc.31261 10.1016/j.pathol.2019.07.014 10.1016/S1470-2045(06)70731-8 10.3390/v9100267 10.1002/ijc.29143 10.1158/0008-5472.CAN-05-3066 10.1038/bjc.2011.351 10.1016/0002-9378(95)90279-1 10.1002/cjp2.110 10.1097/AOG.0000000000000669 10.1136/bmj.g130 10.1016/j.cmi.2019.09.006 10.2807/1560-7917.ES.2018.23.41.1700737 10.1001/jama.2018.10400 10.3310/hta23280 10.17061/phrp2921914 10.5694/mja2.50223 10.5858/arpa.LGT200570 10.1016/j.vaccine.2018.11.075 10.1007/978-3-319-11074-5 10.1016/j.jcv.2015.11.015 |
| ContentType | Journal Article |
| Copyright | 2020 UICC 2020 UICC. |
| Copyright_xml | – notice: 2020 UICC – notice: 2020 UICC. |
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7T5 7TO 7U9 H94 K9. 7X8 |
| DOI | 10.1002/ijc.33128 |
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Immunology Abstracts Oncogenes and Growth Factors Abstracts Virology and AIDS Abstracts AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) MEDLINE - Academic |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Immunology Abstracts Virology and AIDS Abstracts Oncogenes and Growth Factors Abstracts MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic MEDLINE AIDS and Cancer Research Abstracts CrossRef |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1097-0215 |
| EndPage | 3074 |
| ExternalDocumentID | 32484236 10_1002_ijc_33128 IJC33128 |
| Genre | article Research Support, Non-U.S. Gov't Journal Article |
| GeographicLocations | Australia |
| GeographicLocations_xml | – name: Australia |
| GrantInformation_xml | – fundername: National Health and Medical Research Council funderid: 568971 |
| GroupedDBID | --- -~X .3N .GA 05W 0R~ 10A 1L6 1OB 1OC 1ZS 24P 33P 3SF 3WU 4.4 4ZD 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 5GY 5VS 66C 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A01 A03 AAESR AAEVG AAHHS AAHQN AAIPD AAMNL AANLZ AAONW AASGY AAXRX AAYCA AAZKR ABCQN ABCUV ABIJN ABJNI ABLJU ABOCM ABPVW ABQWH ABXGK ACAHQ ACCFJ ACCZN ACFBH ACGFO ACGFS ACGOF ACIWK ACMXC ACPOU ACPRK ACXBN ACXQS ADBBV ADBTR ADEOM ADIZJ ADKYN ADMGS ADOZA ADXAS ADZMN ADZOD AEEZP AEGXH AEIGN AEIMD AENEX AEQDE AEUQT AEUYR AFBPY AFFPM AFGKR AFPWT AFRAH AFWVQ AFZJQ AHBTC AHMBA AIACR AIAGR AITYG AIURR AIWBW AJBDE ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN ALVPJ AMBMR AMYDB ATUGU AZBYB AZVAB BAFTC BFHJK BHBCM BMXJE BROTX BRXPI BY8 C45 CS3 D-6 D-7 D-E D-F DCZOG DPXWK DR2 DRFUL DRMAN DRSTM DU5 EBS EMOBN F00 F01 F04 F5P FUBAC G-S G.N GNP GODZA H.X HBH HGLYW HHY HHZ HZ~ IH2 IX1 J0M JPC KBYEO KQQ L7B LATKE LAW LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LYRES MEWTI MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N04 N05 N9A NF~ NNB O66 O9- OIG OK1 OVD P2P P2W P2X P2Z P4B P4D PQQKQ Q.N Q11 QB0 QRW R.K RIWAO ROL RWI RX1 RYL SUPJJ TEORI UB1 UDS V2E V8K V9Y W2D W8V W99 WBKPD WHWMO WIB WIH WIJ WIK WIN WJL WOHZO WQJ WRC WUP WVDHM WWO WXI WXSBR XG1 XPP XV2 ZZTAW ~IA ~WT .55 .GJ .Y3 31~ 3O- 53G 8WZ A6W AAMMB AANHP AAYXX ABEFU ABEML ACBWZ ACRPL ACSCC ACYXJ ADNMO AEFGJ AEYWJ AGHNM AGQPQ AGXDD AGYGG AHEFC AI. AIDQK AIDYY AIQQE ASPBG AVWKF AZFZN BDRZF CITATION EJD EX3 FEDTE GLUZI HF~ HVGLF LW6 M6P PALCI RJQFR SAMSI VH1 WOW X7M Y6R ZGI ZXP CGR CUY CVF ECM EIF NPM 7T5 7TO 7U9 H94 K9. 7X8 |
| ID | FETCH-LOGICAL-c2688-6dc83b1f599074c9f0f5eedcb010daed58edf8a4c5df31120a3bc570706a57bd3 |
| IEDL.DBID | DR2 |
| ISSN | 0020-7136 1097-0215 |
| IngestDate | Fri Jul 11 12:43:06 EDT 2025 Tue Oct 07 06:23:57 EDT 2025 Thu Apr 03 06:59:13 EDT 2025 Wed Oct 01 03:10:22 EDT 2025 Thu Apr 24 23:12:47 EDT 2025 Wed Jan 22 16:32:26 EST 2025 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 11 |
| Keywords | positive predictive value screening cervical cancer human papillomavirus |
| Language | English |
| License | 2020 UICC. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c2688-6dc83b1f599074c9f0f5eedcb010daed58edf8a4c5df31120a3bc570706a57bd3 |
| Notes | Funding information National Health and Medical Research Council, Grant/Award Number: 568971 ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
| ORCID | 0000-0002-2358-4972 |
| PMID | 32484236 |
| PQID | 2449425235 |
| PQPubID | 105430 |
| PageCount | 7 |
| ParticipantIDs | proquest_miscellaneous_2408823232 proquest_journals_2449425235 pubmed_primary_32484236 crossref_primary_10_1002_ijc_33128 crossref_citationtrail_10_1002_ijc_33128 wiley_primary_10_1002_ijc_33128_IJC33128 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 1 December 2020 2020-12-00 2020-12-01 20201201 |
| PublicationDateYYYYMMDD | 2020-12-01 |
| PublicationDate_xml | – month: 12 year: 2020 text: 1 December 2020 day: 01 |
| PublicationDecade | 2020 |
| PublicationPlace | Hoboken, USA |
| PublicationPlace_xml | – name: Hoboken, USA – name: United States – name: Hoboken |
| PublicationTitle | International journal of cancer |
| PublicationTitleAlternate | Int J Cancer |
| PublicationYear | 2020 |
| Publisher | John Wiley & Sons, Inc Wiley Subscription Services, Inc |
| Publisher_xml | – name: John Wiley & Sons, Inc – name: Wiley Subscription Services, Inc |
| References | 2011; 105 2018; 320 2017; 8 2018; 143 2014; 348 2019; 51 2018; 4 2015; 125 2015; 136 2006; 66 2017 Sep 21 2019; 23 2019; 37 2006; 7 2016; 76 2019 2020; 26 2017 2019; 29 2015 2018; 23 2012; 136 1995; 173 2019; 211 e_1_2_9_20_1 e_1_2_9_11_1 e_1_2_9_22_1 e_1_2_9_10_1 e_1_2_9_21_1 e_1_2_9_13_1 e_1_2_9_24_1 e_1_2_9_12_1 e_1_2_9_23_1 e_1_2_9_8_1 e_1_2_9_7_1 e_1_2_9_6_1 e_1_2_9_3_1 e_1_2_9_2_1 Australian Institute for Health and Welfare (e_1_2_9_4_1) 2019 e_1_2_9_9_1 e_1_2_9_15_1 e_1_2_9_14_1 e_1_2_9_25_1 e_1_2_9_17_1 e_1_2_9_16_1 e_1_2_9_19_1 e_1_2_9_18_1 Koliopoulos G (e_1_2_9_5_1) 2017; 8 |
| References_xml | – volume: 66 start-page: 1218 year: 2006 end-page: 1224 article-title: Age‐related changes of the cervix influence human papillomavirus type distribution publication-title: Cancer Res – volume: 4 start-page: 207 year: 2018 end-page: 212 article-title: The new screening program to prevent cervical cancer using HPV DNA: getting the balance right in maintaining quality publication-title: J Pathol Clin Res – volume: 143 start-page: 735 year: 2018 end-page: 745 article-title: Eurogin roadmap 2017: triage strategies for the management of HPV‐positive women in cervical screening programs publication-title: Int J Cancer – volume: 37 start-page: 412 year: 2019 end-page: 416 article-title: Age‐specific HPV prevalence among 116,052 women in Australia's renewed cervical screening program: a new tool for monitoring vaccine impact publication-title: Vaccine – volume: 125 start-page: 330 year: 2015 end-page: 337 article-title: Use of primary high‐risk human papillomavirus testing for cervical cancer screening: interim clinical guidance publication-title: Obstet Gynecol – volume: 320 start-page: 687 year: 2018 end-page: 705 article-title: Screening for cervical cancer with high‐risk human papillomavirus testing: updated evidence report and systematic review for the US preventive services task force publication-title: JAMA – volume: 7 start-page: 547 year: 2006 end-page: 555 article-title: Human papillomavirus testing and liquid‐based cytology in primary screening of women younger than 35 years: results at recruitment for a randomised controlled trial publication-title: Lancet Oncol – volume: 51 start-page: 752 year: 2019 end-page: 755 article-title: Histopathological evaluation of colposcopic biopsies, LLETZ and cold knife cone biopsies of the uterine cervix in post‐menopausal women: considerations in the setting of the new Australian cervical HPV DNA screening program publication-title: Pathology – volume: 136 start-page: 1266 year: 2012 end-page: 1297 article-title: The lower Anogenital squamous terminology standardization project for HPV‐associated lesions: background and consensus recommendations from the College of American Pathologists and the American Society for Colposcopy and Cervical Pathology publication-title: Arch Pathol Lab Med – volume: 29 issue: 2 year: 2019 article-title: Lessons from the renewal of the National Cervical Screening Program in Australia publication-title: Public Health Res Pract – volume: 348 year: 2014 article-title: Long term duration of protective effect for HPV negative women: follow‐up of primary HPV screening randomised controlled trial publication-title: BMJ – volume: 136 start-page: 1665 year: 2015 end-page: 1671 article-title: Age‐stratified 5‐year risks of cervical precancer among women with enrollment and newly detected HPV infection publication-title: Int J Cancer – volume: 173 start-page: 534 year: 1995 end-page: 543 article-title: Determinants of cervical ectopia and of cervicitis: age, oral contraception, specific cervical infection, smoking, and douching publication-title: Am J Obstet Gynecol – volume: 76 start-page: S49 issue: Suppl 1 year: 2016 end-page: S55 article-title: Triage of HPV positive women in cervical cancer screening publication-title: J Clin Virol – year: 2017 – volume: 211 start-page: 113 year: 2019 end-page: 119 article-title: Routine cervical screening by primary HPV testing: early findings in the renewed National Cervical Screening Program publication-title: Med J Aust – volume: 26 start-page: 579 year: 2020 end-page: 583 article-title: Primary HPV‐based cervical cancer screening in Europe: implementation status, challenges, and future plans publication-title: Clin Microbiol Infect – volume: 105 start-page: 877 year: 2011 end-page: 880 article-title: Use of HC2 to triage women with borderline and mild dyskaryosis in the UK publication-title: Br J Cancer – year: 2019 – year: 2017 Sep 21 – year: 2015 – volume: 23 year: 2018 article-title: The impact of 10 years of human papillomavirus (HPV) vaccination in Australia: what additional disease burden will a nonavalent vaccine prevent? publication-title: Euro Surveill – volume: 8 year: 2017 article-title: Cytology versus HPV testing for cervical cancer screening in the general population (review) publication-title: Cochrane Database Syst Rev – volume: 23 start-page: 1 year: 2019 end-page: 44 article-title: HPV testing compared with routine cytology in cervical screening: long‐term follow‐up of ARTISTIC RCT publication-title: Health Technol Assess – ident: e_1_2_9_2_1 – ident: e_1_2_9_17_1 doi: 10.1002/ijc.31261 – ident: e_1_2_9_8_1 doi: 10.1016/j.pathol.2019.07.014 – ident: e_1_2_9_13_1 doi: 10.1016/S1470-2045(06)70731-8 – ident: e_1_2_9_23_1 doi: 10.3390/v9100267 – ident: e_1_2_9_18_1 doi: 10.1002/ijc.29143 – ident: e_1_2_9_21_1 doi: 10.1158/0008-5472.CAN-05-3066 – ident: e_1_2_9_11_1 doi: 10.1038/bjc.2011.351 – ident: e_1_2_9_22_1 doi: 10.1016/0002-9378(95)90279-1 – volume: 8 start-page: CD008587 year: 2017 ident: e_1_2_9_5_1 article-title: Cytology versus HPV testing for cervical cancer screening in the general population (review) publication-title: Cochrane Database Syst Rev – ident: e_1_2_9_25_1 doi: 10.1002/cjp2.110 – volume-title: Cancer in Australia 2019 (Cat No. CAN 119; Cancer Series No. 123) year: 2019 ident: e_1_2_9_4_1 – ident: e_1_2_9_14_1 doi: 10.1097/AOG.0000000000000669 – ident: e_1_2_9_20_1 doi: 10.1136/bmj.g130 – ident: e_1_2_9_15_1 doi: 10.1016/j.cmi.2019.09.006 – ident: e_1_2_9_3_1 doi: 10.2807/1560-7917.ES.2018.23.41.1700737 – ident: e_1_2_9_12_1 doi: 10.1001/jama.2018.10400 – ident: e_1_2_9_19_1 doi: 10.3310/hta23280 – ident: e_1_2_9_7_1 doi: 10.17061/phrp2921914 – ident: e_1_2_9_6_1 doi: 10.5694/mja2.50223 – ident: e_1_2_9_10_1 doi: 10.5858/arpa.LGT200570 – ident: e_1_2_9_24_1 doi: 10.1016/j.vaccine.2018.11.075 – ident: e_1_2_9_9_1 doi: 10.1007/978-3-319-11074-5 – ident: e_1_2_9_16_1 doi: 10.1016/j.jcv.2015.11.015 |
| SSID | ssj0011504 |
| Score | 2.4249067 |
| Snippet | Australia's new HPV‐based cervical screening program is based on an algorithm that incorporates reflex cytology to guide decisions about further follow‐up with... Australia's new HPV-based cervical screening program is based on an algorithm that incorporates reflex cytology to guide decisions about further follow-up with... |
| SourceID | proquest pubmed crossref wiley |
| SourceType | Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 3068 |
| SubjectTerms | Adult Age Age Factors Aged Algorithms Biopsy Cancer Cellular biology Cervical cancer Cervical Intraepithelial Neoplasia - diagnosis Cervical Intraepithelial Neoplasia - epidemiology Cervical Intraepithelial Neoplasia - virology Colposcopy Colposcopy - methods Cytology Early Detection of Cancer Female human papillomavirus Human papillomavirus 16 - isolation & purification Human papillomavirus 18 - isolation & purification Humans Medical research Medical screening Middle Aged Neoplasm Grading Papillomavirus Infections - complications Papillomavirus Infections - virology positive predictive value Referral and Consultation screening Uterine Cervical Neoplasms - diagnosis Uterine Cervical Neoplasms - epidemiology Uterine Cervical Neoplasms - virology |
| Title | Detection of high‐grade cervical disease among women referred directly to colposcopy after a positive HPV screening test varies with age and cytology findings |
| URI | https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fijc.33128 https://www.ncbi.nlm.nih.gov/pubmed/32484236 https://www.proquest.com/docview/2449425235 https://www.proquest.com/docview/2408823232 |
| Volume | 147 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVWIB databaseName: Wiley Online Library - Core collection (SURFmarket) issn: 0020-7136 databaseCode: DR2 dateStart: 19960101 customDbUrl: isFulltext: true eissn: 1097-0215 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0011504 providerName: Wiley-Blackwell |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3LShxBFL2Ii5BNniaZqOEmZJFNjzNdXdXVuBITmQiGIDG4CDTV9RAT6ZaZHmFc-Ql-gt_ml3ir-iHGBELoTUNX0a_7OKce5wK8t4TYdGbIkVxso0QKHmWS_LFgNk1srDKZ-M3Je1_E5CDZPeSHS7DZ7YVp9CH6ATfvGSFeewdXxWzjVjT0-KceMkbhleLvmIlAp_Z76SgPdFoF5lFEREx0qkKjeKPveTcX3QOYd_FqSDg7j-FH96jNOpNfw3ldDPX5byqO__kuT-BRC0Rxq7Gcp7Bky2fwYK-dan8OVx9tHZZplVg59KrG1xeXR1NlLOoQX6hzO7uDoWIRBjEHDHVLptZgkyxPFlhXSNZ2WvkNMAsMRclRYbNa7Mzi5Ot3pNhFfJqyKBLyrfEsEHj0Y8RI8Q5VaVAvQqXdBYZZ9vJotgIHO5--bU-itpxDpGNB_iiMlqwYO555Qq4zN3KcMrQuiBIaZQ2X1jipEs2NYwQDR4oVmqcUk4TiaWHYC1guq9K-AtQJcYLUMSlEmlA_qVw2TjizY0uMXrgBfOh-bK5brXNfcuMkb1Sa45y-eB6--ADe9U1PG4GPPzVa66wjb318lhMwyijixYwP4G1_mbzTT7mo0lZz38ZTGEbHAF42VtXfhaCsJDAr6GGDbfz99vnn3e1w8vrfm67Cw9jbflh5swbL9XRu1wk_1cWb4Cg3mQgYsw |
| linkProvider | Wiley-Blackwell |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3JbtRAEC0lQSJcWBMYCFAgDlw8mXG7222JCwpEk5CJEEpQLshq9xIBkR1NPJGGE5_AJ_BtfAnV7QWFRYqQL5bcLW_1ql718grgmSXGpjNDQHKxjRIpeJRJwmPBbJrYWGUy8ZuTp_ticpjsHvGjJXjR7YVp9CH6ATePjOCvPcD9gPTmL9XQj5_0kDHyr8twJRGUp3hK9K4Xj_JUp9VgHkWUiolOV2gUb_ZdL0ajPyjmRcYaQs72DfjQPWyz0uTzcF4XQ_3lNx3H_32bm3C95aL4sjGeW7Bky9twddrOtt-B769sHVZqlVg59MLGP75-O54pY1EHF0Od2wkeDEWLMOg5YChdMrMGm3h5ssC6QjK408rvgVlgqEuOCpsFY-cWJ2_fI7kvSqkpkCKR3xrPQw6PfpgYyeWhKg3qRSi2u8Aw0V4en63B4fbrg61J1FZ0iHQsCJLCaMmKseOZz8l15kaOU5DWBWWFRlnDpTVOqkRz4xgxwZFiheYpuSWheFoYtg4rZVXae4A6obQgdUwKkSbUTyqXjRPO7NhSUi_cAJ53fzbXrdy5r7pxkjdCzXFOXzwPX3wAT_ump43Gx98abXTmkbcwP8uJG2Xk9GLGB_Ckv0wA9bMuqrTV3LfxWQyjYwB3G7Pq70JsVhKfFfSwwTj-fft8Z3crnNy_fNPHsDo5mO7lezv7bx7AtdgDISzE2YCVeja3D4lO1cWjgJqfGFEc1A |
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3bahRBEC1ihOCLd-Nq1FJ88GU2u9PTPT3gi2RdNtGEIEbyIkNPX4IaZpbNbGB98hP8BL_NL7G65yLxAiL7MrDdzK1O1anp6lMATy0xNp0ZApKLbZRIwaNMEh4LZtPExiqTid-cvH8gZkfJ3jE_XoPn3V6YRh-i_-DmkRH8tQe4nRu3_VM19MNHPWSM_OsluJzwTPqCvsmbXjzKU51Wg3kUUSomOl2hUbzdT70YjX6jmBcZawg502vwvrvYptLk03BZF0P9-Rcdx_-9m-twteWi-KIxnhuwZsubsLHfrrbfgm8TW4dKrRIrh17Y-PuXrycLZSzq4GJocrvAg6FpEQY9BwytSxbWYBMvT1dYV0gGN6_8HpgVhr7kqLApGDu3ODt8h-S-KKWmQIpEfms8Dzk8-s_ESC4PVWlQr0Kz3RWGhfby5Ow2HE1fvt2ZRW1Hh0jHgiApjJasGDue-ZxcZ27kOAVpXVBWaJQ1XFrjpEo0N44RExwpVmieklsSiqeFYXdgvaxKexdQJ5QWpI5JIdKE5knlsnHCmR1bSuqFG8Cz7s3mupU79103TvNGqDnO6Ynn4YkP4Ek_dN5ofPxp0FZnHnkL87OcuFFGTi9mfACP-78JoH7VRZW2WvoxPoth9BvAZmNW_VmIzUris4IuNhjH30-f7-7thIN7_z70EWwcTqb5692DV_fhSuxxEOpwtmC9XiztA2JTdfEwgOYHmfQcWA |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Detection+of+high%E2%80%90grade+cervical+disease+among+women+referred+directly+to+colposcopy+after+a+positive+HPV+screening+test+varies+with+age+and+cytology+findings&rft.jtitle=International+journal+of+cancer&rft.au=Farnsworth%2C+Annabelle&rft.au=Roberts%2C+Jennifer+M.&rft.au=Garland%2C+Suzanne+M.&rft.au=Crescini%2C+Joanne&rft.date=2020-12-01&rft.pub=John+Wiley+%26+Sons%2C+Inc&rft.issn=0020-7136&rft.eissn=1097-0215&rft.volume=147&rft.issue=11&rft.spage=3068&rft.epage=3074&rft_id=info:doi/10.1002%2Fijc.33128&rft.externalDBID=10.1002%252Fijc.33128&rft.externalDocID=IJC33128 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0020-7136&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0020-7136&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0020-7136&client=summon |